CRC for Biomedical Imaging Development (CRCBID) works with practising clinicians, industry and research partners to develop high specificity imaging radiopharmaceuticals for positron emission tomography (PET) and high sensitivity detectors for medical and industrial imaging applications.

Assisting clinicians to detect, diagnose and manage treatment of diseases earlier, through the development of more sensitive and specific disease markers, is the underlying goal of CRCBID.

It is also fostering the growth of Australian expertise in biomedical imaging and building the nation's capacity to serve the needs of researchers, clinicians and industry people working in this field.

CRCBID is a leading edge Australian research company established and supported under the Australian government's Cooperative Research Centres program - further information www.crc.gov.au